Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market
International Business News: NEW DELHI: Biocon Biologics announced that the US Food and Drug Administration (US FDA) has approved the company's application for YESAFILI, the compa.
Source: indiatimes.com